Literature DB >> 24977316

Revival, characterization, and hepatitis B virus infection of cryopreserved human fetal hepatocytes.

Ming Zhou1, Yayun Huang2, Zhikui Cheng1, Fei Zhao1, Jiafu Li3, Xiaoguang Zhi1, Xiaohui Tian1, Weihua Sun2, Kanghong Hu4.   

Abstract

Primary human hepatocytes are considered the ideal cellular model for in-vitro studies of liver-specific pathology, such as hepatitis B virus (HBV) infection. However, poor accessibility, limited cell numbers, and lot-to-lot variation of primary human hepatocytes limit their broad application. Human fetal hepatocytes were isolated from postmortem embryonic liver tissues by two-step collagenase perfusion and cryopreserved. A monolayer of cryopreserved human fetal hepatocytes was established by optimizing such conditions as cell density and viability and purification of viable cells by Percoll. Finally, revived human fetal hepatocytes were characterized and infected with HBV. A large number of viable human fetal hepatocytes could be isolated and cryopreserved, with seeding density and viability being critical for the establishment of a compact monolayer culture. Using low-viability cryopreserved human fetal hepatocytes, a typical monolayer was established by purification with Percoll. The revived cells were actively proliferative, showed identical morphologic characteristics to non-cryopreserved cells, and had a typical hepatic gene expression profile. Moreover, this optimized model was susceptible to HBV infection and could be used to screen entry inhibitors against HBV infection. In conclusion, these methods can be used on human fetal hepatocytes to provide a cell bank for studies of the early stages of HBV infection.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cryopreservation; HBV infection; Human fetal hepatocyte; Revival

Mesh:

Year:  2014        PMID: 24977316     DOI: 10.1016/j.jviromet.2014.06.015

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  6 in total

1.  Establishment and Characterization of an HBV Viral Spread and Infectious System following Long-Term Passage of an HBV Clinical Isolate in the Primary Human Hepatocyte and Fibroblast Coculture System.

Authors:  Yang Liu; Dmytro Kornyeyev; Lindsey May; Dong Han; Thomas Aeschbacher; Silvia Chang; Ross Martin; Hongmei Mo; Becket Feierbach
Journal:  J Virol       Date:  2022-08-29       Impact factor: 6.549

Review 2.  Engineered Livers for Infectious Diseases.

Authors:  Nil Gural; Liliana Mancio-Silva; Jiang He; Sangeeta N Bhatia
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-11-22

3.  hNTCP‑expressing primary pig hepatocytes are a valuable tool for investigating hepatitis B virus infection and antiviral drugs.

Authors:  Ming Zhou; Bo Qin; Xue-Song Deng; Xiao-Li Zeng; Ying Lu; Zi-Gang Huang; Chun-Chen Wu; Li-Sha Mou
Journal:  Mol Med Rep       Date:  2019-08-29       Impact factor: 2.952

4.  Efficient Inhibition of Hepatitis B Virus Infection by a preS1-binding Peptide.

Authors:  Xiaoli Ye; Ming Zhou; Yonggang He; Yanmin Wan; Weiya Bai; Shuai Tao; Yanqin Ren; Xinxin Zhang; Jianqing Xu; Jing Liu; Junqi Zhang; Kanghong Hu; Youhua Xie
Journal:  Sci Rep       Date:  2016-07-07       Impact factor: 4.379

5.  Upregulation of HBV transcription by sodium taurocholate cotransporting polypeptide at the postentry step is inhibited by the entry inhibitor Myrcludex B.

Authors:  Kaitao Zhao; Shuhui Liu; Yingshan Chen; Yongxuan Yao; Ming Zhou; Yifei Yuan; Yun Wang; Rongjuan Pei; Jizheng Chen; Xue Hu; Yuan Zhou; He Zhao; Mengji Lu; Chunchen Wu; Xinwen Chen
Journal:  Emerg Microbes Infect       Date:  2018-11-21       Impact factor: 7.163

6.  Productive HBV infection of well-differentiated, hNTCP-expressing human hepatoma-derived (Huh7) cells.

Authors:  Ming Zhou; Kaitao Zhao; Yongxuan Yao; Yifei Yuan; Rongjuan Pei; Yun Wang; Jizheng Chen; Xue Hu; Yuan Zhou; Xinwen Chen; Chunchen Wu
Journal:  Virol Sin       Date:  2017-09-29       Impact factor: 4.327

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.